Ed the histopathological features of the PLB samples using the Metavir

Differences of P Does not prolong long-term [3 survival . Sarasin and others noted that only] causes of the elevation of these levels was an immune response. When the serum level of ALT or hyaluronic acid was maintained at a normal level for a few months in the early period or for six months in the late period after LDLT, we gradually decreased the dose of immunosuppressants. When the PLB score was A2 or F2, we increased the dose of immunosuppressants to provide the early treatment of portal inflammation or fibrosis. When the PLB grade was A0 and F0, we gradually decreasedthe dose of immunosuppressants. Statistical analysis The significance of the differences between two groups SART.S23503 was evaluated using the chi-squared test. Associations between the recipient, donor or graft variables and abnormal histopathological findings were evaluated using univariate and backward selection multivariate Cox regression methods. A ROC curve analysis was performed to identify the cutoff value for the correlation between the ALT level and abnormal histopathological findings. All statistical analyses were performed using the StatView software package (SAS Institute, Cary, NC) and EZR (Saitama Medical Center, Jichi Medical University, Japan).Ed the histopathological features of the PLB samples using the Metavir scoring system[11], which grades the activity (A), i.e., the amount of inflammation (specifically, the intensity of necro-inflammatory lesions), on a four-point scale from A0 to A3.Ed the histopathological features of the PLB samples using the Metavir scoring system[11], which grades the activity (A), i.e., the amount of inflammation (specifically, the intensity of necro-inflammatory lesions), on a four-point scale from A0 to A3. Fibrosis (F) was graded on a five-point scale from F0 to F4. Strategy of increasing the dose of immunosuppressants after LDLT When the serum level of ALT or hyaluronic acid was found to be high in outpatients, we increased the dose of immunosuppressants if the suspected causes of the elevation of these levels was an immune response. When the serum level of ALT or hyaluronic acid was maintained at a normal level for a few months in the early period or for six months in the late period after LDLT, we gradually decreased the dose of immunosuppressants. When the PLB score was A2 or F2, we increased the dose of immunosuppressants to provide the early treatment of portal inflammation or fibrosis. When the PLB grade was A0 and F0, we gradually decreasedthe dose of immunosuppressants. Statistical analysis The significance of the differences between two groups SART.S23503 was evaluated using the chi-squared test. Associations between the recipient, donor or graft variables and abnormal histopathological findings were evaluated using univariate and backward selection multivariate Cox regression methods. A ROC curve analysis was performed to identify the cutoff value for the correlation between the ALT level and abnormal histopathological findings.